OSR Health (OSRHW) Research & Development (2024 - 2025)
OSR Health (OSRHW) posted Research & Development of -$1794.0 for Q3 2025, down 103.35% sequentially from $53525.0 in Q2 2025, and down 103.28% YoY from $54705.0 in Q3 2024.
OSR Health (OSRHW) Research & Development (2024 - 2025) Analysis & Trends
OSR Health has reported Research & Development for 2 years, with the latest figure at -$1794.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 413.13 Mn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn | -588.31 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 97.90 Mn |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn | 210.03 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,794.00 |
| Jun 30, 2025 | 53,525.00 |
| Mar 31, 2025 | 90,149.00 |
| Sep 30, 2024 | 54,705.00 |
| Jun 30, 2024 | 45,259.00 |
| Mar 31, 2024 | 46,715.00 |